Remove 2013 Remove Due Diligence Remove Governance Remove Pharmaceutical Industry
article thumbnail

Terrorist (Litigation) Threats

Drug & Device Law

6, 2022) (legislative power to “deem” something as “consent” to personal jurisdiction in JASTA cannot so deem actions that could not otherwise support jurisdiction consistently with Due Process). So the plaintiffs perverted JASTA to target American and other western pharmaceutical companies, rather than terrorists and their shadowy sponsors.